Evidence map›Paper›PMID 42479737›Full record

ArticlePLOS digital health2026

Artificial intelligence risk prediction model for common respiratory pathogens in China based on heterogeneous multi-source clinical and geographic data: A modeling study.

Hongyu Wang, Qianqian Zhang, Binhuang Sun, Dan Shen, Lingling Lu, Huan Li, Kai Fang, Hongyang Li, Hui Yan, Feiying Chen and 7 more

Abstract read
In one paragraph

Article in PLOS digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Hongyu WangDepartment of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.
Qianqian ZhangSchool of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID https://orcid.org/0000-0003-2825-6238
Binhuang SunDepartment of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.
Dan ShenKey Laboratory of Digital Technology in Medical Diagnostics of Zhejiang Province, Dian Diagnostics Group Co., Ltd., Hangzhou, China.
Lingling LuInfection Technology Platform, Dian Diagnostics Group Co., Ltd., Hangzhou, China.
Huan LiSales & Marketing Center, Dian Diagnostics Group Co., Ltd., Hangzhou, China.
Kai FangShanghai Sci-Tech Inno Center for Infection & Immunity, Shanghai, China.
Hongyang LiShanghai Sci-Tech Inno Center for Infection & Immunity, Shanghai, China.
Hui YanShanghai Sci-Tech Inno Center for Infection & Immunity, Shanghai, China.
Feiying ChenShanghai Sci-Tech Inno Center for Infection & Immunity, Shanghai, China.
Tingting ZhaoShanghai Sci-Tech Inno Center for Infection & Immunity, Shanghai, China.
Ling ChenShanghai Sci-Tech Inno Center for Infection & Immunity, Shanghai, China.
Mengyu RongShanghai Sci-Tech Inno Center for Infection & Immunity, Shanghai, China.
Wen LiuShanghai Sci-Tech Inno Center for Infection & Immunity, Shanghai, China.
Zengyun HuSchool of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jingwen AiDepartment of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.ORCID https://orcid.org/0000-0002-5152-1557
Wenhong ZhangDepartment of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most respiratory pathogens exhibit distinct seasonal and periodic outbreak patterns driven by climatic factors. However, predictive models that jointly consider climate, air quality index (AQI), and socioeconomic variables are lacking. We retrospectively analyzed targeted or metagenomic next-generation sequencing data from 153,544 respiratory samples collected from 1,880 centers across 30 provinces in China between September 2022 and September 2024. Monthly positivity rates were matched with geographic, climatic, AQI, and GDP data. CO(0.098 ± 0.016), HCHO(0.096 ± 0.021), O3(0.102 ± 0.019), sunshine hours(0.103 ± 0.028), wind speed(0.114 ± 0.024), and GDP(0.095 ± 0.019). were identified as the key geographical factors for the positivity across most respiratory pathogens via mean Gini index reduction, and a gradient boosting decision tree(GBDT) model was trained and benchmarked against other AI methods using the DISO metric. This model accurately simulated the epidemiological trends from September 2022 to September 2024 and outperformed alternative models with the lowest DISO metric of 0.12 in influenza A, 0.21 in SARS-CoV-2, 0.25 in RSV. The GBDT model was used to predict the short-term epidemic of 10 respiratory pathogens between October and December 2024. The predictions showed consistent trends with the external validation cohort for RNA viruses including SARS-CoV-2 and influenza A virus, but differed for bacterial pathogens. Integrating air quality, climatic, and socioeconomic data yields robust predictions of respiratory infection dynamics in the short-term by the GBDT model, bolstering public health surveillance and offering a framework potentially applicable to other infectious diseases.

Identifiers

PMID42479737
PMCPMC13387545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.